Novadiscovery

company

About

Health tech company using clinical trial simulation technology to predict drug efficacy and optimize clinical trial development.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
€2.50M
Industries
Artificial Intelligence,Biotechnology,CRM,Health Care,Information Technology,Medical
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enabling scientists and biotech, pharma companies to predict drug efficacy and create the target combination.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2.50M
Novadiscovery has raised a total of €2.50M in funding over 2 rounds. Their latest funding was raised on Feb 16, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 16, 2021 Series A €2.50M 1 Sanofi Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Novadiscovery is funded by 1 investors. Sanofi are the most recent investors.
Investor Name Lead Investor Funding Round
Sanofi Yes Series A